Nancy university hospital
Nancy, Lorraine, 54000, France
Location status: Recruiting
NCT Number: NCT06503588
The Committee of Infectiology of the French Association of Urology (CIAFU) provided, for the first time in 2020, comprehensive guidelines for ureteral stent-associated urinary tract infections (USAUTI) prevention, diagnosis and treatment. Since evidence lacked in terms of appropriate treatment, guidelines could not support systematic change of US in case of USAUTI.
This study aims to evaluate whether "after guidelines group" patients treated for USAUTI had different occurrence of at least one relapse or recurrence than "before guidelines group".
Interested in participating?
Request InfoAll sexes
Observational
Nancy, Lorraine, 54000, France
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Guidelines promoting surgical abstention
Time frame: 1 year
Time frame: 1 year
Acute kidney injury ; hematuria ; pain ; stent migration or incrustation
Time frame: 1 year
Sepsis or septic shock
Time frame: 1 year
all cause death
Time frame: 1 year
antibiotics' WHO classifcation
Contact information is provided by the study sponsor or research team.
Benjamin Lefevre, M.D. PhD
CONTACT
Tahani Sara
CONTACT
Central Hospital, Nancy, France
Other
Ureteral Stent Exchange Abstention in Urinary Tract Infections: a Before-and-after Study to Assess Guidelines' Impact on Patients' Outcomes
Acronym: JJ-change-UTI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07555964
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Angers, France
View Trial DetailsNCT06976125
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Cleveland, Ohio, United States
View Trial DetailsNCT07559318
Antiobiotic Stewardship, Communicable Diseases
Melun, France
View Trial DetailsNCT05711446
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
New York, United States
View Trial Details